Navigation Links
TCS Named as a Leader in Life Science Drug Safety Services by Leading Industry Research Firm
Date:2/28/2013

MUMBAI, India, Feb. 28, 2013 /PRNewswire/ -- Tata Consultancy Services (TCS), (BSE: 532540, NSE: TCS) a leading IT services, consulting and business solutions organization, announced that it has been designated as a Leader in Life Science Drug Safety Services (DSS) by the prominent global market intelligence firm IDC. Among the attributes that earned TCS its leadership position in the "IDC MarketScape: Worldwide Life Science Drug Safety Services 2013 Vendor Assessment" (Document # HI239221) are the company's significant industry expertise, strong drug safety IT and KPO delivery capabilities and investment in drug safety specific IP assets.

IDC MarketScape reports are designed to identify factors conducive to success in a particular market, both long term and short term, and then assess vendors participating in the market against these factors. The criteria for each IDC MarketScape report is developed by IDC analysts and can include discussions, surveys and interviews. For this report, the key criteria for defining excellence included: breadth of service offerings, diversity of resources and infrastructure-supporting services delivery, project experience in the Life Sciences DSS outsourcing market, customer service strategy and customer satisfaction, pricing model, go-to-market capabilities and commitment to growth and innovation in the R&D DSS space.

"TCS' large Life Science customer base, broad industry-centric services portfolio, competitive pricing, and strong commitment to growth ensure that the company will continue to be a leading service provider to the industry over both the near and long term," said the report's author, Alan S. Louie , Ph.D., Research Director, Clinical Development Strategy and Technology, IDC Health Insights.

"For TCS and our Life Sciences customers, patient safety is the absolute priority and we are honored to be listed as a Leader by IDC Health Insights in the Drug Safety market," said Debashis Ghosh , President, Life Sciences, Manufacturing and Energy at TCS. "This recognition is a testament to our commitment to our customers, of constantly innovating and delivering superior drug safety services, and helping companies in ensuring enhanced care for their patients."

"To be named as a Leader in the Drug Safety Market by IDC Health Insights is indeed a recognition of our differentiated strategy of providing core business services by investing in deep domain expertise and regulatory knowledge. TCS' market leading capabilities in the drug safety space, including adverse event tracking and aggregate reporting, help the pharmaceutical industry meet their compliance requirements more effectively," said Abid Ali Neemuchwala , Global Head, TCS BPO Services.

TCS' drug safety services help customers enhance efficiency, reduce costs significantly and ensure regulatory compliance. TCS' customers benefit from the company's domain knowledge, global reach, quality systems approach, multi-disciplinary safety expertise and adherence to reporting timelines of the EMEA, FDA, MHRA and other industry authorities.

About IDC MarketScape
IDC MarketScape vendor analysis model is designed to provide an overview of the competitive fitness of IT, telecommunications, or industry-specific suppliers in a given market. The research methodology utilizes a rigorous scoring methodology based on both qualitative and quantitative criteria that results in a single graphical illustration of each vendor's position within a given market. IDC MarketScape provides a clear framework in which the product and service offerings, capabilities and strategies, and current and future market success factors of IT, telecommunications, or industry-specific vendors can be meaningfully compared. The framework also provides technology buyers with a transparent foundation to allow companies to independently compare the strengths and weaknesses of current and prospective vendors.

About TCS Life Sciences
Top Global Life Sciences organizations derive value from TCS' full services play in IT, Consulting, KPO, Infrastructure and Engineering Services as well as new age business solutions including Mobility and Big Data. TCS' rich industry experience, domain expertise and global footprint ensures that it partners with its Life Sciences customers to help them advance clinical trial efficiencies, accelerate drug discovery, maximize manufacturing productivity and improve sales and marketing effectiveness. In addition, TCS has a dedicated Life Sciences Innovation Lab which ensures that its customers have the tools and innovative solutions they need to solve complex business challenges. 

About TCS BPO
Business Process Services (BPO) at TCS is about managing and executing business operations. Our domain expertise helps deliver core business processing across industries, analytics and insights and support processes such as accounting, HR and supply chain management. TCS partners with customers to accelerate co-transformation, and generates business value for customers through delivery excellence, risk management and through innovative models such as Platform BPO, which delivers process as a service. With over $1.4 billion in BPO revenues and 45,000+ employees across 11 countries delivering services to over 225+ customers, TCS is one of the leading Global Domain based BPO providers.

About Tata Consultancy Services Ltd (TCS)
Tata Consultancy Services is an IT services, consulting and business solutions organization that delivers real results to global business, ensuring a level of certainty no other firm can match. TCS offers a consulting-led, integrated portfolio of IT, BPO, infrastructure, engineering and assurance services. This is delivered through its unique Global Network Delivery Model™, recognized as the benchmark of excellence in software development. A part of the Tata Group, India's largest industrial conglomerate, TCS has over 263,000 of the world's best trained consultants in 44 countries. The Company generated consolidated revenues of US $ 10.17 billion for year ended 31 March, 2012 and is listed on the National Stock Exchange and Bombay Stock Exchange in India. For more information, visit us at www.tcs.com.

Follow TCS on Twitter.
Subscribe to an RSS Feed of TCS Press Releases.


'/>"/>
SOURCE Tata Consultancy Services
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Prime Therapeutics named a 2013 National Top Workplace
2. Rafarma Pharmaceuticals, Inc. Named 1 Of 4 National Strategic Pharmaceutical Suppliers To The Russian Federation
3. Cohera Medical Named Winner of 2013 Carnegie Science Award
4. PharmaNet/i3 Renamed inVentiv Health Clinical
5. Randy Gaboriault of Christiana Care Health System Named Computerworld Premier 100 IT Leader
6. Heraeus Named "Supplier of the Year" by National Association of Dental Laboratories
7. AbbVie Named to S&P 500 Dividend Aristocrat Index
8. Roche Diagnostics Named to FORTUNE magazines 2013 list of "100 Best Companies to Work For"
9. Ferring Pharmaceuticals Inc. Named 10th Fastest Growing New Jersey Company
10. Kareo Named a Top Workplace by the Orange County Register
11. Jack Cochran, MD, Executive Director of The Permanente Federation at Kaiser Permanente, named to National Quality Forum Board
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2017)... 27, 2017  ImMAGE Biotherapeutics (OTCMKTS: IMMG), an early-stage ... early toxicology and efficacy studies. The company is harnessing ... specific protein, MAGE A, in an effort to find ... After 4 weeks of treatment in transgenic ... little toxicity in a full toxicology report of various ...
(Date:3/27/2017)... March 27, 2017  Sanderling Ventures, portfolio company, ... a division of Johnson & Johnson. Torax manufactures and ... treatment of gastro-esophageal reflux disease (GERD). The LINK ... technology and the procedure is currently available in ... Torax Medical was founded by Sanderling Ventures, Mayo ...
(Date:3/27/2017)... March 27, 2017 BioLineRx Ltd. (NASDAQ/TASE: ... announced today that AGI-134, an immunotherapy for the treatment of ... Ltd., will be featured at the upcoming American Association ... Washington, DC to be held on April 1-5, ... ...
Breaking Medicine Technology:
(Date:3/27/2017)... ... 27, 2017 , ... Buzzies parent company, The TouchPoint Solution’s CEO and co-founder, ... and UBS’ Project Entrepreneur. Mayo will present her pitch about the lifestyle wearable devices, ... second annual venture competition ignites bold ideas by providing women access to the tools, ...
(Date:3/27/2017)... ... March 27, 2017 , ... American Veterinarian™, the leading multimedia ... medicine, announces the launch of Veterinarian’s Money Digest™, a business and financial resource ... of American Veterinarian™. , “We look forward to launching Veterinarian’s Money ...
(Date:3/27/2017)... ... March 27, 2017 , ... ... products enables researchers to pursue the recent RNA methylation “gold rush” with their ... light of the newfound characteristics of N6-methyladenosine, or m6A , RNA methylation ...
(Date:3/27/2017)... (PRWEB) , ... March 27, 2017 , ... According to ... prostate cancer, including all stages, is more than 95%. Once the cancer spreads to ... less than 30%. To find out how to avoid this latter group, tune in ...
(Date:3/27/2017)... ... March 27, 2017 , ... ?Grow Healthy Vending ... the pending litigation between itself and 1800 Vending DBA Healthy You Vending. (Civil ... am thrilled to announce that we have now reached a settlement agreement regarding ...
Breaking Medicine News(10 mins):